Skip to content

Telenursing and Breast Cancer: The Turkish Case

A Randomized Controlled Study on the Influence of Telenursing Services to the Chemotherapy Treatment of Breast Cancer Patients: The Turkish Case

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04480229
Enrollment
96
Registered
2020-07-21
Start date
2016-05-06
Completion date
2017-06-22
Last updated
2020-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female

Keywords

telenursing, breast cancer, chemotherapy, symptom management

Brief summary

This study aims to determine the effectiveness of telenursing services on chemotherapy symptoms and comfort levels in patients with breast cancer in Turkey.

Detailed description

This study aims to determine the effectiveness of telenursing services on chemotherapy symptoms and comfort levels in patients with breast cancer in Turkey. The study employs an experimental research methodology with a sample of 96 ambulatory patients (48 experimental, 48 control) who were receiving chemotherapy for breast cancer for the first time in a state hospital. Research data were collected by using Patient Information Form, Edmonton Symptom Assessment Scale, General Comfort Questionnaire, Symptoms Follow-up Form, and Telephone Call Form. The experimental group received telenursing service every week until the end of the four-cycle chemotherapy treatment, which started one week after the first treatment. The control group did not receive any intervention. Investigators analyzed data with SPSS 15.0 (Statistical Package for the Social Sciences) with comparative statistical methods of MannWhitney U Test, Chi-Square Test, One Way Analysis of Variance in Repeated Measurements, and Pearson Correlation.

Interventions

BEHAVIORALTelenursing and Counseling

After the first face-to-face training, counseling on the phone was conducted every week for four cycles of chemotherapy treatment. In total, six counseling sessions and four face-to-face training sessions were conducted for each patient.

Sponsors

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* is volunteering to participate in the research, * is 18 years of age or over, * can communicate in Turkish, * has Turkish literacy skills, * has no hearing, vision problems, and mental disability that may hinder communication, * is female, * has a diagnosis of breast cancer for the first time in her life and consequently receiving chemotherapy treatment in the same protocols for the first time, * did not have a different diagnosis of cancer and related chemotherapy treatment.

Exclusion criteria

* Having been diagnosed with breast cancer before and received chemotherapy treatment accordingly, * Having been diagnosed with different cancers before and had chemotherapy treatment related to it, * Cancer treatment with oral medications, * Refuse to participate in the study * Refuse education/counseling * Not knowing Turkish

Design outcomes

Primary

MeasureTime frameDescription
Edmonton Symptom Assessment System10 minutesThis tool is designed to assist in the assessment of symptoms common in cancer patients: pain,fatique, nausea, sadness, anxiety, insomnia, anorexia, wellbeing and shortness of breath, change in skin-nails, mucositis and numbness in hands. The patient circles the most appropriate number to indicate where the symptom is between 0 and 10. 0 is the minimum value, which means there is no change and it is a better outcome for the patient. 10 is the maximum value, means that the symptom level is the highest, which is a worse outcome for the patient.

Secondary

MeasureTime frameDescription
General Comfort Questionnaire10 minutesIt is used to evaluate the situation of achieving the expected comfort increase result with nursing interventions that provide comfort. The scale, which is a four-point likert type, has a total of 48 items, 24 items are positive and 24 items are negative. The lowest value that can be taken is 1 which indicates low comfort and this is a worse outcome. The highest value 4 indicates high comfort, which is a better outcome. The response patterns of the scale, which consists of positive and negative items, are given in mixed form. Accordingly, from positive statements; high score (4p) indicates high comfort, low score (1p) indicates low comfort, while negative items indicate low comfort (1p), high score (4p) low comfort.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026